Vascular endothelial growth factor and dendritic cells in human squamous cell carcinoma of the oral cavity

Anticancer Research

Volumn 26, Issue 3 A, 2006, Pages 1833-1848

  Kikuchi, Kentaro ^a   Kusama, Kaoru ^b   Sano, Makoto ^a   Nakanishi, Yoko ^a   Ishige, Toshiyuki ^a,b   Ohni, Sumie ^a   Oinuma, Toshinori ^a   Nemoto, Norimichi ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

Author keywords

CD1A; CD83; Dendritic cells; Oral squamous cell carcinoma; VEGF; VEGFR

Indexed keywords

CD83 ANTIGEN; MESSENGER RNA; RECOMBINANT VASCULOTROPIN; T6 ANTIGEN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ADULT; AGED; ARTICLE; CELL DENSITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; SQUAMOUS CELL CARCINOMA; STEM CELL; TUMOR IMMUNITY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD1; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL LINE, TUMOR; DENDRITIC CELLS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33745601411     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Banchereau J and Steinman RM: Dendritic cells and the control of immunity. Nature 392: 245-252, 1998.
2. Shurin MR: Dendritic cells presenting tumor antigen. Cancer Immunol Immunother 43: 158-164, 1996.
3. Goldman SA, Baker E, Weyant RJ, Clarke MR, Myers JN and Lotze MT: Peritumoral CD1a-positive dendritic cells are associated with improved survival in patients with tongue carcinoma. Arch Otolaryngol Head Neck Surg 124: 641-646, 1998.
4. Wei N and Tahan SR: S-100⊕ cell response to squamous cell carcinoma of the lip: inverse correlation with metastasis. J Cutan Pathol 25: 463-468, 1998.
5. Kikuchi K, Kusama K, Taguchi K, Ishikawa F, Okamoto M, Shimada J, Sakashita H and Yamamoto Y: Dendritic cells in human squamous cell carcinoma of the oral cavity. Anticancer Res 22: 545-557, 2002.
6. Gallo O, Libonati GA, Gallina E, Fini-Storchi O, Giannini A, Urso C and Bondi R: Langerhans cells related to prognosis in patients with laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 777: 1007-1010, 1991.
7. Matuda H, Mori M, Tsujitani S, Ohno S, Kuwano H and Sugimachi K: Immunohistochemical evaluation of squamous cell carcinoma antigen and S-100 protein-positive cells in human malignant esophageal tissues. Cancer 65: 2261-2265, 1990.
8. Tsujitani S, Furukawa T, Tamada R, Okamura T, Yasumoto K and Sugimachi K: Langerhans cells and prognosis in patients with gastric carcinoma. Cancer 59: 501-505, 1987.
9. Nakayama Y, Inoue Y, Minagawa N, Katsuki T, Matsumoto K, Shibao K, Tsurudome K, Hirata K, Sako T, Nagata N and Itoh H: Relationships between S-100 protein-positive cells and clinicopathological factors in patients with colorectal cancer. Anticancer Res 23: 4423-4426, 2003.
10. Furukawa T, Watanabe S, Kodama T, Sato Y, Shimosato Y and Suematu K: T-zone histiocytes in adenocarcinoma of the lung in relation to postoperative prognosis. Cancer 56: 2651-2656, 1985.
11. Schroder S, Schwarz W, Rehpenning W, Loning T and Bocer W: Dendritic/Langerhans cells and prognosis in patients with papillary thyroid carcinomas: immunocytochemical study of 106 thyroid neoplasms correlated to follow-up data. Am J Clin Pathol 89: 295-300, 1988.
12. Nakano T, Oka K, Arai T, Morita S and Tsunemoto H: Prognostic significance of Langerhans' cell infiltration in radiation therapy for squamous cell carcinoma of the uterine cervix. Arch Pathol Lab Med 113: 507-511, 1989.
13. Iwamoto M, Shinohara H, Miyamoto A, Okuzawa M, Mabuchi H, Nohara T, Gon G, Toyoda M and Tanigawa N: Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas. Int J Cancer 104: 92-97, 2003.
14. Gabrilovich DI, Chen HL, Girgin KR, Cunningham T, Meny GM, Nadaf S, Kavanaugh D and Carubon DP: Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 2: 1096-1103, 1996.
15. Saito H, Tsujitani S, Ikeguchi M, Maeta M and Kaibala N: Relationsip between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue. Br J Cancer 78: 1573-1577, 1998.
16. Takahashi A, Kono K, Itakura J, Amemiya H, Tang RF, Iizuka H, Fujii H and Matsumoto Y: Correlation of vascular endothelial growth factor-C expression with tumor-infiltrating dendritic cells in gastric cancer. Oncology 62: 121-127, 2002.
17. Homer JJ, Anyanwu K, Ell SR, Greenman J and Stafford ND: Serum vascular endothelial growth factor in patients with head and neck squamous cell carcinoma. Clin Otolaryngol 24: 426-430, 1999.
18. Kumar H, Heer K, Lee PWR, Duthie GS, MacDonald AW, Greenman J, Kerin MJ and Monson JRT: Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer. Clin Cancer Res 4: 1279-1285, 1998.
19. Yamamoto Y, Toi M, Kondo S, Matsumoto T, Suzuki H, Kitamura M, Tsuruta K, Taniguchi T, Okamoto A, Mori T, Yoshida M, Ikeda T and Tominaga T: Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clin Cancer Res 2: 821-826, 1996.
20. Sobin LH and Wittekind CH: International Union Against Cancer (UICC): TNM classification of malignant tumours (Japanese Edition). In: Head and Neck Tumors, fifth edition. Tokyo: Kanehara Corp., pp. 17-24, 1998.
21. Spiessl B, Scheibe O and Wagner G: International Union Against Cancer (UICC): TNM Atlas - Illustrated Guide to the Classification of Malignant Tumours. In: Spiessl B, Scheibe O and Wagner G (eds.): Head and Neck Tumors. Berlin, Heidelberg, New York: Springer-Verlag, pp. 1-7, 1982.
22. Tanimoto K, Akbar F, Michitaka K and Onji M: Immunohistochemical localization of antigen presenting cells in liver from patients with primary biliary cirrhosis; highly restricted distribution of CD83-positive activated dendritic cells. Pathol Res Pract 195: 157-162, 1999.
23. Shintani S, Kiyota A, Mihara M, Nakahara Y, Terakado N, Ueyama Y and Matsumura T: Association of preoperative radiation effect with tumor angiogenesis and vascular endothelial growth factor in oral squamous cell carcinoma. Jpn J Cancer Res 91: 1051-1057, 2000.
24. Romani N, Gruner S, Brang D, Kampgen E, Lenz A, Trockenbacher B, Konwalinka G, Fritsch PO, Steinman RM and Schuler G: Proliferating dendritic cell progenitors in human blood. J Exp Med 180: 83-93, 1994.
25. Nicol D, Hii S, Walsh M, Teh B, Thompson L, Kennett C and Gotly D: Vascular endothelial growth factor expression is increased in renal cell carcinoma. J Urol 157: 1482-1486, 1997.
26. Pujol BF, Lucibello FC, Gehling UM, Weidner KLN, Adamkiewicz MZJ, Muller HER and Havemann K: Endothelial-like cells derived from human CD14 positive monocytes. Differentiation 65: 287-300, 2000.
27. Pujol BF, Lucibello FC, Zuzarte M, Lutjens P, Muller R and Havemann K: Dendritic cells derived from peripheral monocytes express endothelial markers and in the presence of angiogenic growth factors differentiate into endothelial-like cells. EJCB 80: 99-110, 2001.
28. + human blood dendritic cells for active tumor immunotherapy. Exp Hematol 25: 232-237, 1997.
29. Tsujitani S, Oka A, Kondo A, Ikeguchi M, Maeta M and Kaibara N: Infiltration of dendritic cells into regional lymph nodes in gastric cancer. Cancer 75: 1478-1483, 1995.
30. Spiro RH, Alfonso AE, Farr HW and Strong EW: Cervical node metastasis from epidermoid carcinoma of the oral cavity and oropharynx. A critical assessment of current staging. Am J Surg 128: 562-567, 1974.
31. Lucas AD and Halliday GM: Progressor but not regressor skin tumours inhibit Langerhans' cell migration from epidermis to local lymph nodes. Immunol 97: 130-137, 1999.
32. Buelens C, Willems F, Delvaux A, Pierard G, Delville JP, Velu T and Goldman M: Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells. Eur J Immunol 25: 2668-2672, 1995.
33. Lu L, Li W, Fu F, Chambers FG, Qian S, Fung JJ and Thomson AW: Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation 64: 1808-1815, 1997.
34. Weidner N, Carroll PR, Flax J, Blumenfeld W and Folkman J: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143: 401-409, 1993.
35. Gasparini G, Weidner N, Maluta S, Pozza F, Boracchi P, Mezzetti M Testolin A and Bevilacqua P: Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous-cell carcinoma. Int J Cancer 55: 739-744, 1993.
36. Srivastava A, Laidler P, Davies RP, Morgan K and Hughes LE: The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study. Am J Pathol 133: 419-423, 1988.
37. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, Sawada T and Sowa M: Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 77: 858-863, 1996.
38. Kajita T, Ohta Y, Kimura K, Tamura M, Tanaka Y, Tsunezuka Y, Oda M, Sasaki T and Watanabe G: The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer. Br J Cancer 85: 255-260, 2001.
39. Santin AD, Hermonat PL, Ravaggi A, Cannon MJ, Pecorelli S and Parham GP: Secretion of vascular endothelial growth factor in ovarian cancer. Eur J Gynaecol Oncol 20: 177-181, 1999.
40. Takano S, Yoshii Y, Kondo S, Suzuki H, Maruno T, Shirai S and Nose T: Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res 56: 2185-2190, 1996.
41. Almand B, Resser JR, Lindman B, Nadaf S, Clark JI, Kwon ED, Carbone DP and Gabrilovich DI: Clinical significance of defective dendritic cell differentiation in cancer. Clin Cancer Res 6: 1755-1766, 2000.
42. Ohm JE and Carbone DP: VEGF as a mediator of tumor-associated immunodeficiency. Immunol Res 23: 263-272, 2001.
43. Ohm JE and Carbone DP: Immune dysfunction in cancer patients. Oncol 16: 11-18, 2002.
44. Schwaab T, Weiss JE, Schned AR and Barth RJ Jr: Dendritic cell infiltration in colon cancer. J Immunother 24: 130-137, 2001.
45. Zhou L-N, Schwarting R, Smith HM and Tedder TF: A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J Immunol 149: 735-742, 1992.
46. Bell D, Chomarat P, Broyles D, Netto G, Harb GM, Lebecque S, Valladeau J, Davoust J, Palucka KA and Banchereau J: In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med 190: 1417-1425, 1999.
47. Gabrilovich D, Ishida T, Oyama T, Ran S, Kravtsov V, Nadaf S and Carbone DO: Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 92: 4150-4166, 1998.
48. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ and Moore MW: Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442, 1996.
49. Brooks SP, Bernstein ZP, Schneider SL, Gollnick SO and Tomasi TB: Role of transforming growth factor-beta 1 in the suppressed allostimulatory function of AIDS patients. AIDS 12: 481-487, 1998.